SCHEMBL4493791

SCHEMBL4493791

CCOC(=O)c1ccc(-n2ccc3c(OC4CCN(C(=O)OC(C)(C)C)CC4)cccc32)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 9/20 0.71
PDE4D Q08499 3/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49
KDM1A O60341 1/20 0.44
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 1/20 0.42
HTR6 P50406 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3930276 0.87 GPR119 (0.54) GPR119PDE4BNPSR1ALDH1A1LMNA
SCHEMBL3929129 0.86 GPR119 (0.78) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL3935155 0.84 GPR119 (0.76) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL3931381 0.83 GPR119 (0.75) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL4490826 0.80 GPR119 (0.71) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL1375168 0.78 GPR119 (0.61) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL2979574 0.75 GPR119 (0.54) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL3941387 0.74 GPR119 (0.61) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL13986467 0.73 PDE4D (0.47) GPR119PDE4DPDE4APDE4BPDE4C
SCHEMBL20046236 0.73 GPR119 (0.55) GPR119PDE4DPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222261-B2 Chemical compounds GlaxoSmithKline, LLC (US) 2012-07-17 US disclosed
US-20090318477-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318477-A1 CHEMICAL COMPOUNDS GPR119, GOT2, SLC5A2 GPR119 1/4885PDE4D 1484/4885PDE4A 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.